Recombinant Staphylococcus saprophyticus subsp. saprophyticus Monofunctional glycosyltransferase (mgt)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mgt; SSP0919; Monofunctional glycosyltransferase; MGT; Peptidoglycan TGase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-270
Protein Length
full length protein
Species
Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229)
Target Names
mgt
Target Protein Sequence
MKRSDRYKTYNKPNDSNDSNQLHHNTYFKPVNKPQKKKKGKGIILKLLIPILIIIGIIIG VMYALSLRADTDELKNITEKESFVYASDMRDYTKGAFIAMEDERFYKHHGFDVKGTSRAL FSTLSDKSVQGGSTITQQVVKNYYYDNEQSITRKIKELFVAHRVEKEYDKNEILSFYMNN IYYGSDQYTIESAANHYFGVTTDKNNPNLPQISVLQSAILASKINAPSVYNINDMSDNFT NRVKTDLEKMKQQGYISNSQYENAIQELGV
Uniprot No.

Target Background

Function

This recombinant Staphylococcus saprophyticus subsp. saprophyticus monofunctional glycosyltransferase (mgt) is a peptidoglycan polymerase. It catalyzes glycan chain elongation using lipid-linked disaccharide-pentapeptide as a substrate.

Database Links

KEGG: ssp:SSP0919

STRING: 342451.SSP0919

Protein Families
Glycosyltransferase 51 family
Subcellular Location
Cell membrane; Single-pass membrane protein.

Q&A

What is Monofunctional Glycosyltransferase (mgt) in Staphylococcus saprophyticus?

Monofunctional glycosyltransferase (MGT) in Staphylococcus saprophyticus is a bacterial enzyme involved in cell wall biosynthesis. While specific characterization in S. saprophyticus is limited, research on homologous proteins in S. aureus indicates that MGT catalyzes the incorporation of UDP-N-acetylglucosamine into peptidoglycan, a critical component of bacterial cell walls . The mgt gene encodes this enzyme, which shares significant sequence homology with MGTs from gram-negative bacteria and the N-terminal glycosyltransferase domain of class A high-molecular-mass penicillin-binding proteins from various bacterial species . In S. aureus, MGT contains an N-terminal hydrophobic domain likely involved in membrane association, suggesting a similar structure-function relationship may exist in S. saprophyticus .

How does S. saprophyticus MGT structure compare to other Staphylococcal species?

Based on comparative genomic analyses, S. saprophyticus MGT likely shares structural similarities with S. aureus MGT, which has been more extensively characterized. Circular dichroism analysis of purified S. aureus MGT revealed secondary structural elements consistent with predicted structures, suggesting proper protein folding . The enzyme typically contains an N-terminal hydrophobic domain that anchors it to the bacterial membrane, while the catalytic domain extends into the periplasmic space . When expressing recombinant MGT, researchers often use truncated versions lacking the hydrophobic domain to improve solubility while maintaining enzymatic activity . Genomic analyses of S. saprophyticus populations indicate that while there are distinct clades with differential gene content, core cellular functions like cell wall synthesis are likely conserved across the species .

What experimental approaches are recommended for expressing recombinant S. saprophyticus MGT?

For expressing recombinant S. saprophyticus MGT, a methodological approach similar to that used for S. aureus MGT is recommended. This typically involves:

  • Gene cloning: Isolate the mgt gene from S. saprophyticus genomic DNA using PCR with specific primers designed based on genome sequence data .

  • Expression vector construction: Clone the gene into an appropriate expression vector with a strong promoter system, considering whether to express the full-length protein or a truncated version lacking the N-terminal hydrophobic domain for improved solubility .

  • Host selection: Express the protein in Escherichia coli, which has been successfully used for S. aureus MGT . Common E. coli strains such as BL21(DE3) are preferred for recombinant enzyme expression .

  • Purification strategy: Incorporate an affinity tag (His-tag or GST-tag) to facilitate purification using affinity chromatography, followed by size exclusion chromatography to achieve high purity .

  • Activity verification: Confirm enzymatic activity by measuring the incorporation of UDP-N-acetylglucosamine into peptidoglycan using either radiometric assays or the universal glycosyltransferase continuous (UGC) assay .

How do genetic recombination patterns in S. saprophyticus affect mgt gene diversity?

Genetic recombination patterns in S. saprophyticus populations significantly impact gene diversity, including that of cell wall biosynthesis genes like mgt. Genomic analyses have shown that S. saprophyticus has a recombination to mutation (r/m) ratio of approximately 1.2, similar to S. aureus with an r/m of ~1 . This indicates a moderate contribution of horizontal gene transfer (HGT) to core genome diversification compared to species with wider host ranges like Campylobacter jejuni (r/m = 150) and Listeria monocytogenes (r/m = 85) .

The impact of this recombination rate on mgt gene diversity is multifaceted:

  • Clade-specific barriers: S. saprophyticus populations exhibit distinct genetic clades with evidence of reproductive isolation and rare recombination between clades . This clade structure may lead to differential evolution of the mgt gene between subpopulations.

  • Restriction-modification systems: Differences in restriction-modification systems (RMS) between S. saprophyticus clades create mechanistic barriers to horizontal gene transfer . These systems may protect the mgt gene from frequent recombination events, potentially preserving function-critical sequences.

  • Metabolic adaptation: Differential maintenance of metabolic genes between clades suggests that S. saprophyticus subpopulations adapt to distinct ecological niches . This ecological specialization may indirectly influence selection pressures on cell wall biosynthesis genes like mgt.

Researchers investigating mgt gene diversity should consider these population genetic structures and implement appropriate sampling strategies that capture representatives from different clades to understand the full spectrum of genetic variation.

What methodologies are most effective for assessing MGT enzymatic activity?

For rigorous assessment of S. saprophyticus MGT enzymatic activity, several complementary methodologies should be employed:

Universal Glycosyltransferase Continuous (UGC) Assay

The UGC assay represents a significant advancement for glycosyltransferase activity measurement, allowing real-time monitoring of reaction kinetics . This method:

  • Measures declining NADH concentration through fluorescence spectrophotometry to determine reaction rates .

  • Couples nucleotide release from glycosyltransferase reactions with pyruvate kinase via nucleoside diphosphate kinase (NDK) .

  • Offers higher accuracy compared to endpoint assays by enabling continuous monitoring of reaction progression .

  • Is adaptable to various nucleotide donors (UDP, GDP, and CMP), making it versatile for different glycosyltransferases .

Moenomycin Inhibition Assay

Based on findings with S. aureus MGT, moenomycin A inhibition can be used as a verification method for authentic MGT activity . This approach:

  • Confirms the specificity of the observed glycosyltransferase activity.

  • Provides a control mechanism by demonstrating inhibition with a known glycosyltransferase inhibitor.

  • Can be used to calculate inhibition parameters (IC50, Ki) to compare sensitivity between MGT variants.

Product Characterization

Confirming that the reaction product is authentic peptidoglycan by:

  • Lysozyme sensitivity testing: Authentic peptidoglycan products will be sensitive to lysozyme degradation .

  • Mass spectrometry: Characterization of reaction products to confirm incorporation of N-acetylglucosamine into peptidoglycan structures.

  • Structural analysis: Nuclear magnetic resonance (NMR) or high-performance liquid chromatography (HPLC) to verify product composition and linkage.

How do restriction-modification systems in S. saprophyticus affect recombinant MGT production?

Restriction-modification systems (RMS) in S. saprophyticus present significant challenges for recombinant MGT production, as these systems are designed to protect bacteria from foreign DNA by selectively degrading unmethylated DNA sequences . The impact on recombinant production manifests in several ways:

  • Clade-specific RMS profiles: Different clades of S. saprophyticus maintain substantially different RMS genes, creating variable barriers to DNA exchange . This variability necessitates clade-specific strategies for gene cloning and expression.

  • Expression host compatibility: When cloning S. saprophyticus mgt into expression hosts like E. coli, researchers must consider potential restriction sites within the gene sequence. Methylation patterns in the donor and recipient organisms influence transformation efficiency and genetic stability .

  • Recombinant vector design: Strategic vector design can mitigate RMS-related challenges by:

    • Incorporating the appropriate methylation patterns using hosts with complementary methyltransferase systems

    • Modifying restriction sites through silent mutations without altering the amino acid sequence

    • Using shuttle vectors that can propagate in both E. coli and Staphylococcus species

  • Gene synthesis alternatives: For particularly problematic sequences, commercial gene synthesis with codon optimization and restriction site modification may circumvent RMS barriers entirely .

A methodological approach for addressing RMS-related challenges includes pre-screening S. saprophyticus strains for RMS profiles, selecting expression systems with compatible methylation patterns, and potentially co-expressing methyltransferases specific to the S. saprophyticus RMS to protect the mgt sequence during cloning and expression.

What are the challenges in expressing active recombinant S. saprophyticus MGT?

Expressing active recombinant S. saprophyticus MGT presents several significant challenges that researchers must address to achieve successful outcomes:

Membrane Association and Solubility

The N-terminal hydrophobic domain of MGT, which likely mediates membrane association, often reduces solubility when expressed in heterologous systems . Strategies to address this include:

  • Truncation approaches: Removing the hydrophobic N-terminal domain while preserving the catalytic domain, as successfully implemented with S. aureus MGT .

  • Fusion protein systems: Creating fusion constructs with solubility-enhancing partners such as maltose-binding protein (MBP) or thioredoxin.

  • Membrane mimetic environments: Utilizing detergents, nanodiscs, or liposomes to stabilize the full-length protein in a membrane-like environment.

Protein Folding and Activity

Ensuring proper folding of the recombinant enzyme is critical for maintaining activity:

  • Expression conditions optimization: Modifying temperature, induction parameters, and culture media composition to promote proper folding .

  • Chaperone co-expression: Co-expressing molecular chaperones to assist with protein folding.

  • Activity verification: Using circular dichroism analysis to confirm that secondary structural elements match predicted structures, suggesting proper folding .

Co-factor Requirements

MGT activity may depend on specific co-factors or conditions:

  • Divalent cations: Testing various metal ions (Mg²⁺, Mn²⁺, Ca²⁺) as potential cofactors for optimal enzymatic activity.

  • pH and ionic strength optimization: Establishing optimal reaction conditions through systematic variation of buffer components.

  • Substrate availability: Ensuring access to the appropriate UDP-N-acetylglucosamine substrate and acceptor molecules .

How does MGT function relate to antibiotic resistance mechanisms?

The relationship between MGT function and antibiotic resistance mechanisms in S. saprophyticus is multifaceted and represents an important area for antimicrobial research:

  • Cell wall biosynthesis inhibition: Since MGT catalyzes a critical step in peptidoglycan synthesis, it is functionally related to the targets of β-lactam antibiotics, which inhibit transpeptidation in cell wall assembly . Alterations in MGT expression or activity could potentially compensate for the inhibition of other cell wall synthesis enzymes.

  • Structural similarities to penicillin-binding proteins: MGT shares significant homology with the N-terminal glycosyltransferase domain of class A high-molecular-mass penicillin-binding proteins (PBPs) . This structural relationship suggests potential functional overlap or compensation mechanisms between MGT and PBPs under antibiotic pressure.

  • Potential resistance pathways: Several potential mechanisms could link MGT to antibiotic resistance:

    • Upregulation of mgt expression to compensate for inhibited PBPs

    • Structural modifications affecting binding of glycosyltransferase inhibitors like moenomycin

    • Altered cell wall composition leading to reduced permeability to certain antibiotics

  • Experimental approaches: To investigate these relationships, researchers should consider:

    • Comparing mgt expression levels in antibiotic-resistant versus susceptible isolates

    • Generating knockout or overexpression mutants to evaluate changes in antibiotic susceptibility profiles

    • Screening for structural variants of MGT in clinical isolates with varied antibiotic resistance patterns

What recombinant expression systems are optimal for S. saprophyticus MGT?

Selecting the optimal expression system for S. saprophyticus MGT requires careful consideration of several factors:

Prokaryotic Expression Systems

E. coli-based systems offer several advantages for MGT expression:

  • High yield potential and rapid growth

  • Well-established genetic tools and expression vectors

  • Successful precedent with S. aureus MGT expression

Recommended E. coli strains include:

StrainAdvantagesBest Applications
BL21(DE3)High expression levels, reduced protease activityInitial expression screening
C41(DE3)/C43(DE3)Better tolerance for membrane proteinsFull-length MGT with hydrophobic domain
RosettaEnhanced expression of proteins with rare codonsIf S. saprophyticus uses rare codons
SHuffleImproved disulfide bond formationIf MGT structure contains disulfide bonds

Gram-positive expression hosts may provide a more native-like environment:

  • Bacillus subtilis expression systems for secreted protein production

  • Non-pathogenic Staphylococcus species for homologous expression

  • Cell-free expression systems derived from gram-positive bacterial extracts

Vector Selection

Vector features that enhance MGT expression success include:

  • Inducible promoter systems (T7, tac, or tet) for controlled expression

  • Fusion tags that enhance solubility (SUMO, MBP) and purification (His, GST)

  • Signal sequences for potential periplasmic targeting or secretion

  • Codon optimization for the chosen expression host

How can researchers effectively study MGT inhibition for antimicrobial development?

For effective study of MGT inhibition as a potential antimicrobial target, researchers should implement a systematic approach:

High-Throughput Screening Methodology

  • Adapt the Universal Glycosyltransferase Continuous (UGC) assay for high-throughput format :

    • Miniaturize reactions for microplate format

    • Optimize signal-to-noise ratio for fluorescence detection

    • Implement automated liquid handling for consistent results

  • Develop a screening cascade:

    • Primary screen: Single-concentration inhibition assay

    • Secondary screen: Dose-response curves for hit confirmation

    • Counter-screen: Rule out interference with coupled enzymes in the assay system

Time-Dependent Inhibition Analysis

Time-dependent inhibition is particularly important to characterize, as demonstrated in studies with other glycosyltransferases :

  • Implement multi-timepoint measurements to detect changes in inhibition profiles over time

  • Calculate and compare IC50 values at different time points to identify time-dependent inhibitors

  • Apply appropriate kinetic models to distinguish between reversible and irreversible inhibition mechanisms

Structure-Activity Relationship Studies

Once inhibitors are identified, systematic structure-activity relationship studies should be conducted:

  • Synthesize analog series to map binding determinants

  • Correlate structural features with inhibitory potency using quantitative structure-activity relationship (QSAR) modeling

  • Assess selectivity against human glycosyltransferases to predict potential toxicity issues

Whole-Cell Validation

Confirm that MGT inhibitors identified in biochemical assays retain activity in bacterial cells:

  • Determine minimum inhibitory concentrations (MICs) against S. saprophyticus

  • Evaluate activity against clinical isolates with various resistance profiles

  • Assess impact on cell wall integrity using microscopy techniques

What genomic approaches can reveal mgt gene diversity across S. saprophyticus populations?

Understanding mgt gene diversity across S. saprophyticus populations requires comprehensive genomic approaches:

Whole Genome Sequencing Strategy

  • Population sampling: Collect diverse isolates representing different:

    • Geographic regions

    • Host species (human, animal)

    • Clinical versus environmental sources

    • Identified genetic clades

  • Sequencing approach:

    • Short-read sequencing for high-throughput comparative genomics

    • Long-read sequencing for complete genome assembly, including mobile genetic elements

    • Targeted deep sequencing of the mgt locus to capture rare variants

Phylogenetic and Population Genetic Analysis

  • Core genome analysis:

    • Align mgt sequences across populations

    • Calculate nucleotide diversity (π) and sequence divergence

    • Identify recombination events using tools like ClonalFrameML

  • Selection pressure analysis:

    • Calculate dN/dS ratios to identify selective pressures on the mgt gene

    • Implement codon-based likelihood methods to detect site-specific selection

    • Compare mgt evolution rates with housekeeping genes

Functional Genomics Approaches

  • Transcriptomic analysis:

    • RNA-seq to quantify mgt expression under various conditions

    • Identify potential regulatory elements affecting expression

  • Experimental validation:

    • Heterologous expression of diverse mgt variants

    • Enzymatic characterization to correlate sequence variation with functional differences

    • Site-directed mutagenesis to validate the impact of specific polymorphisms

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.